CXCL12 and cervical carcinoma: A recent paper indicated that in cervical cancer cells, epigenetic reactivation of CXCL12 was observed when cells are treated with both methylation-inhibiting and acetylating agents, suggesting that in cervical cancer also, methylation and histone acetylation may participate to control the CXCL12 expression level [26].